Lv73
5000 积分 2023-04-23 加入
SDP-LIV1, a Novel and Optimized LIV-1 Antibody–Drug Conjugate Demonstrating Superior Antitumor Efficacy and a Favorable Safety Profile for the Treatment of Solid Tumors
13天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
19天前
已完结
Antibody–drug conjugates come of age in oncology
28天前
已完结
Author Correction: Head and neck squamous cell carcinoma
1个月前
已完结
The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma
1个月前
已完结
Pan-cancer Comprehensive Analysis Identified EGFR as a Potential Biomarker for Multiple Tumor Types
1个月前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
1个月前
已完结
Linker Design for The Antibody Drug Conjugates: A Comprehensive Review
1个月前
已完结
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer
1个月前
已完结
Comparison of Antibodies for Immunohistochemistry-based Detection of HER3 in Breast Cancer
1个月前
已完结
皖公网安备34019202002308
